These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15853711)

  • 41. In vivo antisense imaging.
    Tavitian B
    Q J Nucl Med; 2000 Sep; 44(3):236-55. PubMed ID: 11105588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymeric radiotracers in nuclear imaging.
    Wen X; Cao X; Pasuelo MJ; Wendt R; Li C
    Curr Drug Deliv; 2004 Oct; 1(4):377-84. PubMed ID: 16305399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications.
    Costantini DL; Hu M; Reilly RM
    Cancer Biother Radiopharm; 2008 Feb; 23(1):3-24. PubMed ID: 18298325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging.
    Bengel FM; Anton M; Avril N; Brill T; Nguyen N; Haubner R; Gleiter E; Gansbacher B; Schwaiger M
    Circulation; 2000 Aug; 102(9):948-50. PubMed ID: 10961956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
    Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
    Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
    Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
    Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo molecular-genetic imaging.
    Blasberg RG; Gelovani-Tjuvajev J
    J Cell Biochem Suppl; 2002; 39():172-83. PubMed ID: 12552617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-to-date review of nuclear medicine applications in pediatric thoracic imaging.
    Kwatra NS; Grant FD; Lim R; Lee EY
    Eur J Radiol; 2017 Oct; 95():418-427. PubMed ID: 27142495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC; Jiang X; Elliott RL; Head JF
    Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radioactive drugs. Modern diagnosis and treatment with "hot drugs"].
    Grillenberger K
    Med Monatsschr Pharm; 2002 Dec; 25(12):418-24. PubMed ID: 12522912
    [No Abstract]   [Full Text] [Related]  

  • 53. Nuclear Medicine Imaging of Infection.
    Connolly CM; Donohoe KJ
    Semin Roentgenol; 2017 Apr; 52(2):114-119. PubMed ID: 28606309
    [No Abstract]   [Full Text] [Related]  

  • 54. Dosimetry and optimization of in vivo targeting with radiolabeled antisense oligodeoxynucleotides: oligonucleotide radiotherapy.
    Kairemo KJ; Jekunen AP; Tenhunen M
    Methods Enzymol; 2000; 314():506-24. PubMed ID: 10565036
    [No Abstract]   [Full Text] [Related]  

  • 55. Antisense oligonucleotides as therapeutic agents.
    Galderisi U; Cascino A; Giordano A
    J Cell Physiol; 1999 Nov; 181(2):251-7. PubMed ID: 10497304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
    Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
    Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of antisense technology to urologic cancers.
    Tomita Y
    Mol Urol; 2000; 4(2):55-9. PubMed ID: 12006243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Future direction of renal positron emission tomography.
    Szabo Z; Xia J; Mathews WB; Brown PR
    Semin Nucl Med; 2006 Jan; 36(1):36-50. PubMed ID: 16356795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reporter gene imaging.
    Youn H; Chung JK
    AJR Am J Roentgenol; 2013 Aug; 201(2):W206-14. PubMed ID: 23883235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir.
    Deng WP; Wu CC; Lee CC; Yang WK; Wang HE; Liu RS; Wei HJ; Gelovani JG; Hwang JJ; Yang DM; Fu YK; Wu CW
    J Nucl Med; 2006 May; 47(5):877-84. PubMed ID: 16644759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.